I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 16 studies | 42% ± 17% | |
| oligodendrocyte precursor cell | 14 studies | 35% ± 17% | |
| dendritic cell | 12 studies | 28% ± 9% | |
| endothelial cell | 9 studies | 23% ± 7% | |
| astrocyte | 9 studies | 28% ± 10% | |
| conventional dendritic cell | 8 studies | 27% ± 12% | |
| microglial cell | 8 studies | 23% ± 8% | |
| adipocyte | 8 studies | 25% ± 6% | |
| macrophage | 8 studies | 28% ± 9% | |
| non-classical monocyte | 6 studies | 23% ± 7% | |
| plasmacytoid dendritic cell | 6 studies | 22% ± 4% | |
| myeloid cell | 6 studies | 24% ± 3% | |
| regulatory T cell | 6 studies | 16% ± 1% | |
| monocyte | 6 studies | 24% ± 8% | |
| natural killer cell | 6 studies | 17% ± 2% | |
| CD4-positive, alpha-beta T cell | 5 studies | 18% ± 1% | |
| classical monocyte | 5 studies | 26% ± 4% | |
| glutamatergic neuron | 4 studies | 32% ± 8% | |
| interneuron | 4 studies | 25% ± 9% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 17% ± 1% | |
| mast cell | 4 studies | 22% ± 5% | |
| T follicular helper cell | 4 studies | 17% ± 2% | |
| mononuclear phagocyte | 3 studies | 28% ± 9% | |
| glycinergic amacrine cell | 3 studies | 21% ± 2% | |
| B cell | 3 studies | 17% ± 1% | |
| GABAergic neuron | 3 studies | 29% ± 1% | |
| alveolar macrophage | 3 studies | 29% ± 8% | |
| endothelial cell of lymphatic vessel | 3 studies | 18% ± 2% | |
| pericyte | 3 studies | 20% ± 2% |
